|
|
Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.
In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.
As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.
More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.
In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.


